World Experts Come Together At Columbia For First International Symposium On Childhood And Adolescent Non-Hodgkin's Lymphoma

Columbia, NewYork-Presbyterian Hospital Experts Have Answers to Your Questions

What are the genetic origins of childhood non-Hodgkin's lymphoma? What are the new genetic methods of diagnosis and classification of childhood non-Hodgkin's lymphoma? What is the cure rate for childhood B-cell lymphoma? Are there new approaches to stem cell transplants and vaccine therapy in childhood non-Hodgkin’s lymphoma? Does antibody therapy work? Are there new treatments available to reduce complications? What are the chances of long-term survival in childhood non-Hodgkin’s lymphoma? Childhood non-Hodgkin's lymphoma is a type of cancer in which malignant cells are found in the lymphatic system. This type of cancer can spread to almost any part of the body, including the liver, bone marrow, and spleen. Non-Hodgkin’s lymphoma is diagnosed in 500-700 children a year in the United States. Through a collaborative effort, Columbia University College of Physicians & Surgeons, the Pediatric Cancer Research Foundation, and the University of Giessen in Germany will sponsor the first International Symposium on Childhood and Adolescent Non-Hodgkin’s Lymphoma for pediatric cancer specialists from around the world. The conference will be held in New York City, April 10-12, 2003, to present the latest scientific and clinical advances in childhood, adolescent, and young adult hematological malignancies, stem cell transplantation and immunobiology. Mitchell S. Cairo, M.D., professor of pediatrics, medicine and pathology at Columbia University College of Physicians & Surgeons and director of pediatric blood and marrow transplantation at the Herbert Irving Comprehensive Cancer Center and at the Children’s Hospital of NewYork-Presbyterian, is chair of the symposium.

# # #